Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:39 PM
Ignite Modification Date:
2025-12-24 @ 7:39 PM
NCT ID:
NCT00850603
Eligibility Criteria:
Inclusion Criteria :
* 18 to 55 years of age.
* Willing to return for 3 follow-up visits and comply with a 30 day follow-up period.
* Signed an informed consent form.
Exclusion Criteria :
* Allergy to any component of the vaccine and latex.
* Known or suspected immunodeficiency or receipt of immunosuppressive therapy or blood products within the previous two months.
* History of serious chronic diseases (such as cardiac or renal disease).
* Acute febrile illness at the time of visit.
* Pregnancy.
* Receipt of any vaccine within the 28 days prior to enrollment.
* Receipt of meningococcal vaccine (example in Military) within the past 5 years or history of meningococcal disease.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT00850603
Study Brief:
Protocol Section:
NCT00850603